Physician

Jacques Joseph Youssef, M.D.

According to 2025 Medicare claims, Jacques Youssef, M.D. (NPI: 1699963835) practices nephrology in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is KIDNEY SPECIALISTS OF PADUCAH PLLC (NPI: 1740765957; TIN: 831141225) and primary practice location at 42003-7942. Youssef is affiliated with the IRCCO (ACO ID: A2619) and The Rural Advantage LLC (ACO ID: A5257), participating under the MSSP model.

Youssef's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 959 traditional Medicare patients, billed 4,989 HCPCS/CPT codes, and received $340,433 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,057 prescription claims across 688 beneficiaries totaling $516,397 in drug costs, led by Auryxia (Ferric Citrate). DME data shows 56 claims. Open Payments data shows 35 records totaling $637. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $169,024 to $516,397. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $448 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	875	2,666	$207,734
2016	1,177	5,637	$343,106
2017	1,280	5,350	$349,080
2018	1,343	5,176	$429,534
2019	1,340	5,129	$469,436
2020	1,201	5,586	$403,038
2021	1,327	6,393	$472,505
2022	1,087	5,808	$383,431
2023	1,015	4,228	$329,451
2024	959	4,989	$340,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	296	1,037	$169,024
2016	481	2,091	$240,595
2017	556	2,412	$132,612
2018	615	2,845	$175,946
2019	572	2,633	$343,620
2020	560	2,543	$427,586
2021	654	2,716	$385,819
2022	661	2,633	$555,568
2023	672	2,889	$558,997
2024	688	3,057	$516,397

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	13	$569
2018	N/R	48	$2,303
2019	N/R	52	$1,863
2020	N/R	250	$108,027
2021	N/R	145	$73,888
2022	N/R	93	$2,057
2023	N/R	75	$1,427
2024	N/R	56	$1,041

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	184	212	$139
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	163	163	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	509	909	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	256	811	$63
90935	Hemodialysis procedure with physician evaluation	101	237	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Auryxia	Ferric Citrate	70	2,700	$135,504
Farxiga	Dapagliflozin Propanediol	77	3,690	$68,192
Jardiance	Empagliflozin	57	2,834	$54,212
Velphoro	Sucroferric Oxyhydroxide	14	480	$47,793
Rayaldee	Calcifediol	12	360	$13,332

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	13	$355
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$251
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	15	$210

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$637	Fresenius USA Marketing, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jacques Joseph Youssef, M.D.?

Tedicare shows public-source Medicare data for Jacques Joseph Youssef, M.D. (NPI 1699963835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacques Joseph Youssef, M.D. have ACO affiliation data?

Jacques Joseph Youssef, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and The Rural Advantage LLC (MSSP, ACO ID A5257).

What billing organization is linked to Jacques Joseph Youssef, M.D.?

Jacques Joseph Youssef, M.D. is linked to KIDNEY SPECIALISTS OF PADUCAH PLLC (billing NPI 1740765957) in the available physician profile data.

Does Jacques Joseph Youssef, M.D. have Open Payments data?

Jacques Joseph Youssef, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.